Saffron for Mood: The Clinical Trial Evidence

Saffron (Crocus sativus) is the world's most expensive spice, and one of the most surprising mood supplements in clinical research. Multiple randomized controlled trials have found that saffron extract at 30mg/day produces antidepressant effects comparable to fluoxetine (Prozac) and imipramine for mild-to-moderate depression, with fewer side effects than SSRIs when the trials are pooled (Shafiee et al., 2025). The saffron extract market is growing from $469M to an estimated $1.1B by 2033, driven by this clinical evidence. Here's what the science shows and which products deliver.

As an Amazon Associate I earn from qualifying purchases.

The SSRI comparison: what the studies found

The headline finding that draws people to saffron: in multiple head-to-head RCTs, 30mg/day of saffron extract matched fluoxetine (20mg/day) for reducing depression scores on the Hamilton Depression Rating Scale (HDRS) over 6-8 weeks (Noorbala et al., 2005), and the same 30mg dose matched imipramine 100mg/day over 6 weeks (Akhondzadeh et al., 2004). The results were statistically equivalent: a 2025 meta-analysis of 8 head-to-head trials found no significant difference between saffron and SSRIs for depression, and about 6 percentage points fewer people reporting adverse events on saffron (Shafiee et al., 2025), although single trials, including the first fluoxetine comparison, found no significant side-effect difference. That side-effect edge matters because sexual dysfunction, weight gain and GI disturbance are the side effects that cause many patients to discontinue SSRIs.

Important caveats: These studies were conducted in patients with mild-to-moderate depression. Saffron has NOT been tested head-to-head against SSRIs for severe depression, and should not be considered a replacement for prescription antidepressants in moderate-to-severe cases. Most studies were conducted by research groups in Iran (where saffron is culturally significant and readily available), and larger, more diverse trials are needed. The evidence is genuine and replicated, but the scope is narrower than headlines suggest. The largest pooled analysis so far, 34 placebo-controlled trials and 1,769 adults, found saffron significantly lowered self-rated depression (Beck Depression Inventory) and anxiety (Beck Anxiety Inventory) scores, but not clinician-rated scales such as the HDRS, with the certainty of evidence rated moderate (Mahmoudi et al., 2026).

Mechanism: In laboratory and animal research, saffron's active compound crocin is thought to inhibit serotonin reuptake (the same mechanism as SSRIs) while safranal modulates GABA-A receptors (similar to benzodiazepines but far milder); a systematic review attributes saffron's antidepressant effects to serotonergic, antioxidant, anti-inflammatory, neuro-endocrine and neuroprotective actions (Lopresti and Drummond, 2014). This dual serotonin+GABA mechanism may explain why saffron addresses both depression and anxiety, something that differentiates it from single-mechanism supplements. For comparison, ashwagandha primarily targets cortisol (HPA axis), and rhodiola primarily targets dopamine/serotonin balance under stress.

Beyond depression: other evidence

Anxiety, 7.0/10: Multiple studies show anxiolytic effects at around 30mg/day: pooled across 6 trials, saffron lowered Beck Anxiety Inventory scores (Mahmoudi et al., 2026), and 28mg a day of the affron extract reduced stress and anxiety symptoms in adults with low mood (Kell et al., 2017). Safranal's GABA modulation provides calming effects without sedation. Stacks well with L-Theanine from the Cognitive Stack for combined calm focus.

PMS symptoms, 6.5/10: RCTs have found saffron reduced PMS-related mood symptoms and discomfort: in a placebo-controlled trial of women aged 20 to 45, 30mg/day over two menstrual cycles reduced total premenstrual symptoms and Hamilton depression scores (Agha-Hosseini et al., 2008). The serotonergic mechanism is relevant since PMS mood symptoms are partly driven by cyclical serotonin fluctuations.

Cognitive function, 6.0/10 (emerging): Crocin and crocetin show neuroprotective and anti-inflammatory properties in preclinical models. In older adults with mild-to-moderate Alzheimer's disease, 30mg/day of saffron performed similarly to donepezil 10mg/day over 22 weeks, with less vomiting (Akhondzadeh et al., 2010). Research is early but positions saffron as a potential Cognitive Stack addition.

Sexual function, 6.5/10: Interestingly, while SSRIs commonly cause sexual dysfunction, saffron may improve it. Two RCTs found saffron improved erectile function in men (Modabbernia et al., 2012) and arousal, lubrication and pain in women (Kashani et al., 2013), both in depressed patients experiencing fluoxetine-induced sexual dysfunction, with side effects no more frequent than placebo. This makes saffron a potential adjunct to SSRI treatment, not just an alternative.

Best saffron supplements

#2: NOW Foods Saffron 50mg ($33.99/60 caps, about $0.57 a capsule, as of October 2026)

More saffron per capsule (50mg vs 30mg), but a different kind of saffron: NOW uses whole saffron stigma powder, not an extract, standardized to a minimum of 10% total crocins, in veg capsules (NOW Foods). That makes the 50mg figure not directly comparable to the 30mg extract dose used in the clinical trials, and NOW's product page does not print a daily dose to compare. Extra milligrams may or may not provide additional benefit either way: the dose-response curve for saffron plateaus around 30mg of extract in most studies. At $33.99 for 60 capsules it costs a little more per capsule than our #1 ($0.57 against $0.45). NOW's GMP certification provides quality assurance. Choose this if you prefer whole saffron with a stated crocin standard to a branded extract. Evidence 8.0, Value 9.5, Safety 9.0

Check price on Amazon →

Saffron in the Mood Stack

The Mood Stack adaptogen protocol: Rhodiola (morning energy, $0.62/day) + Saffron (mood elevation, $0.90/day) + Ashwagandha (evening calm, $0.36/day) + Omega-3 (neuroinflammation, $0.62/day). Total: approximately $2.50/day for a comprehensive mood protocol that targets four different mechanisms. Compared to the medical cannabis evidence for depression (5.0/10), this supplement stack has substantially stronger controlled-trial evidence (8.0/10 for saffron alone).

Safety

Saffron extract at 30mg/day is well-tolerated with minimal side effects in clinical studies, and the US Department of Defense's Operation Supplement Safety program says small doses (under 100mg) of saffron extract taken short-term appear to be well tolerated, while noting there is insufficient evidence on safety beyond 26 weeks (OPSS). At very high doses saffron can be toxic: vomiting, dizziness, bloody urine, nausea and headache have been reported especially at 5 grams or more (OPSS), but this requires consuming amounts far beyond any supplement dose. Even 200mg and 400mg saffron tablets for a week in healthy volunteers shifted some blood counts and kidney markers, all within normal ranges, and the 400mg dose lowered standing blood pressure (Modaghegh et al., 2008). Avoid during pregnancy: OPSS advises against amounts above those found in food because saffron could stimulate the uterus. Use caution if taking SSRIs, saffron's serotonergic effect may be additive. The combination has been tested only in short trials: added to existing antidepressants for 8 weeks in 160 adults, affron at 14mg twice daily improved clinician-rated depression scores and did not worsen antidepressant side effects (Lopresti et al., 2019), and in the two 4-week fluoxetine sexual-function trials side effects were no more frequent than placebo. Consult your doctor before combining with antidepressants, and never stop or cut a prescribed antidepressant on your own.

Sources

1. Operation Supplement Safety, US Department of Defense. Saffron dietary supplements. Accessed 19 October 2026.
2. Noorbala AA, et al. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression. J Ethnopharmacol, 2005. Accessed 19 October 2026.
3. Akhondzadeh S, et al. Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression. BMC Complement Altern Med, 2004. Accessed 19 October 2026.
4. Shafiee A, et al. Effect of Saffron Versus Selective Serotonin Reuptake Inhibitors in Treatment of Depression and Anxiety: A Meta-analysis. Nutr Rev, 2025. Accessed 19 October 2026.
5. Mahmoudi R, et al. Effect of saffron on depression, anxiety and mood disorder: a GRADE assessed systematic review and meta-analysis of 34 randomized controlled trials. Nutr Neurosci, 2026. Accessed 19 October 2026.
6. Lopresti AL, Drummond PD. Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action. Hum Psychopharmacol, 2014. Accessed 19 October 2026.
7. Kell G, et al. affron, a novel saffron extract, improves mood in healthy adults over 4 weeks. Complement Ther Med, 2017. Accessed 19 October 2026.
8. Agha-Hosseini M, et al. Crocus sativus L. (saffron) in the treatment of premenstrual syndrome. BJOG, 2008. Accessed 19 October 2026.
9. Akhondzadeh S, et al. A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease. Psychopharmacology, 2010. Accessed 19 October 2026.
10. Modabbernia A, et al. Effect of saffron on fluoxetine-induced sexual impairment in men. Psychopharmacology, 2012. Accessed 19 October 2026.
11. Kashani L, et al. Saffron for treatment of fluoxetine-induced sexual dysfunction in women. Hum Psychopharmacol, 2013. Accessed 19 October 2026.
12. Modaghegh MH, et al. Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers. Phytomedicine, 2008. Accessed 19 October 2026.
13. Lopresti AL, et al. Efficacy of a standardised saffron extract (affron) as an add-on to antidepressant medication. J Psychopharmacol, 2019. Accessed 19 October 2026.
14. Life Extension. Optimized Saffron (product facts and price only). Accessed 19 October 2026.
15. NOW Foods. Saffron 50 mg Veg Capsules (product facts and price only). Accessed 19 October 2026.